In cell culture, IKK inhibition blocks Erb-B2 Receptor Tyrosine Kinase 2 (ERBB2) activation of NF-κB and induces apoptosis in ER negative ERBB2 positive breast cancer cells [148]. Here, NFKB1 is linked to breast carcinoma.